AU2008242488B2 - Benzimidazoles and pharmaceutical compositions thereof - Google Patents

Benzimidazoles and pharmaceutical compositions thereof Download PDF

Info

Publication number
AU2008242488B2
AU2008242488B2 AU2008242488A AU2008242488A AU2008242488B2 AU 2008242488 B2 AU2008242488 B2 AU 2008242488B2 AU 2008242488 A AU2008242488 A AU 2008242488A AU 2008242488 A AU2008242488 A AU 2008242488A AU 2008242488 B2 AU2008242488 B2 AU 2008242488B2
Authority
AU
Australia
Prior art keywords
aryl
alkyl
cycloalkyl
heterocyclic
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008242488A
Other languages
English (en)
Other versions
AU2008242488A1 (en
Inventor
Seung-Yub Lee
Iwao Ojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of AU2008242488A1 publication Critical patent/AU2008242488A1/en
Application granted granted Critical
Publication of AU2008242488B2 publication Critical patent/AU2008242488B2/en
Assigned to THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK reassignment THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK Alteration of Name(s) of Applicant(s) under S113 Assignors: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2008242488A 2007-04-20 2008-04-21 Benzimidazoles and pharmaceutical compositions thereof Ceased AU2008242488B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91298007P 2007-04-20 2007-04-20
US60/912,980 2007-04-20
PCT/US2008/005084 WO2008130669A1 (en) 2007-04-20 2008-04-21 Benzimidazoles and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
AU2008242488A1 AU2008242488A1 (en) 2008-10-30
AU2008242488B2 true AU2008242488B2 (en) 2014-10-30

Family

ID=39875833

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008242488A Ceased AU2008242488B2 (en) 2007-04-20 2008-04-21 Benzimidazoles and pharmaceutical compositions thereof

Country Status (17)

Country Link
US (1) US8232410B2 (enExample)
EP (1) EP2154966B1 (enExample)
JP (1) JP5400032B2 (enExample)
CN (1) CN101677553A (enExample)
AU (1) AU2008242488B2 (enExample)
BR (1) BRPI0810244A2 (enExample)
CA (1) CA2684594C (enExample)
DK (1) DK2154966T3 (enExample)
EA (1) EA016726B1 (enExample)
ES (1) ES2434693T3 (enExample)
HR (1) HRP20131103T1 (enExample)
IN (1) IN2009KN03959A (enExample)
MX (1) MX2009011281A (enExample)
PL (1) PL2154966T3 (enExample)
PT (1) PT2154966E (enExample)
SI (1) SI2154966T1 (enExample)
WO (1) WO2008130669A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8232310B2 (en) 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
US8039502B2 (en) 2007-07-24 2011-10-18 The Ohio State University Research Foundation Anti-infective agents against intracellular pathogens
US20120108823A1 (en) 2009-04-22 2012-05-03 The Ohio State University Research Foundation Anti-francisella agents
BR112012008346B1 (pt) 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
WO2013116823A1 (en) * 2012-02-02 2013-08-08 The Research Foundation Of State University Of New York Benzimidazoles and uses thereof
WO2013142326A1 (en) * 2012-03-23 2013-09-26 The Research Foundation Of State University Of New York 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis
CA2869513C (en) 2012-04-12 2020-07-07 Georgetown University Methods and compositions for treating ewings sarcoma family of tumors
CN103333170B (zh) * 2013-06-14 2016-08-10 清华大学 苯并咪唑类化合物及其用途
AU2014340398A1 (en) 2013-10-24 2016-06-09 Georgetown University Methods and compositions for treating cancer
WO2015077276A1 (en) 2013-11-22 2015-05-28 The Research Foundation For The State University Of New York Benzimidazoles and their use in the treatment of tuberculosis
WO2015138611A2 (en) 2014-03-11 2015-09-17 Colorado State University Research Foundation Methods for improved in vitro-in vivo efficacy determination
KR102582563B1 (ko) * 2014-06-20 2023-09-25 재단법인 한국파스퇴르연구소 항감염 화합물
MX388564B (es) 2014-10-09 2025-03-20 Oncternal Therapeutics Inc Compuestos de indolinona y usos de los mismos.
KR102514814B1 (ko) 2016-03-31 2023-03-27 온크터널 테라퓨틱스, 인코포레이티드. 인돌린 유사체 및 이의 용도
KR102282794B1 (ko) 2016-07-29 2021-07-27 온크터널 테라퓨틱스, 인코포레이티드. 인돌리논 화합물의 용도
CN111303092B (zh) * 2020-04-07 2021-05-25 山东昌邑灶户盐化有限公司 2,4-二硝基-6-氯苯胺衍生物、合成方法及其应用
AU2022306297A1 (en) 2021-07-09 2024-02-08 Plexium, Inc. Aryl compounds and pharmaceutical compositions that modulate ikzf2

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873181A (en) * 1985-01-25 1989-10-10 Fuji Photo Film Co., Ltd. Silver halide photographic material
WO2007105023A1 (en) * 2006-03-15 2007-09-20 Csir Modulation of phosphoryl transferase activity of glutamine synthetase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405235B2 (en) 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
JP4953456B2 (ja) * 2004-09-30 2012-06-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規なベンゾイミダゾール誘導体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873181A (en) * 1985-01-25 1989-10-10 Fuji Photo Film Co., Ltd. Silver halide photographic material
WO2007105023A1 (en) * 2006-03-15 2007-09-20 Csir Modulation of phosphoryl transferase activity of glutamine synthetase

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CAS RN 709635-32-5, STN Entry Date: 14 July 2004 *
KYM, O. et al., "Substituted alpha-Hydroxy and alpha-Methylbenzimidazoles", Berichte Der Deutschen Chemischen Gesellschaft, 1913, Vol. 45, pages 3238-3255 *

Also Published As

Publication number Publication date
EA200901423A1 (ru) 2010-06-30
DK2154966T3 (da) 2013-11-18
JP5400032B2 (ja) 2014-01-29
IN2009KN03959A (enExample) 2015-08-28
WO2008130669A1 (en) 2008-10-30
EA016726B1 (ru) 2012-07-30
EP2154966B1 (en) 2013-08-21
CA2684594A1 (en) 2008-10-30
CA2684594C (en) 2015-10-06
MX2009011281A (es) 2010-03-08
US8232410B2 (en) 2012-07-31
BRPI0810244A2 (pt) 2014-09-30
EP2154966A4 (en) 2010-12-15
SI2154966T1 (sl) 2014-02-28
US20100256203A1 (en) 2010-10-07
CN101677553A (zh) 2010-03-24
HRP20131103T1 (hr) 2013-12-20
PT2154966E (pt) 2013-11-13
PL2154966T3 (pl) 2014-03-31
ES2434693T3 (es) 2013-12-17
EP2154966A1 (en) 2010-02-24
AU2008242488A1 (en) 2008-10-30
JP2010524947A (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
AU2008242488B2 (en) Benzimidazoles and pharmaceutical compositions thereof
CA2821999C (en) Benzimidazole respiratory syncytial virus inhibitors
US10501445B2 (en) Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents
AU2008205169B2 (en) Imidazole derivatives as kinesin spindle protein inhibitors (Eg-5)
CA2873921A1 (en) 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
WO1996018628A1 (en) Alkyl substituted piperadinyl and piperazinyl anti-aids compounds
TWI393708B (zh) 異羥肟酸脂化合物，其用途及其之合成方法
WO2004096793A1 (en) New alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants
JP5746821B2 (ja) ピラゾリルベンゾイミダゾール誘導体、これらを含有する組成物及びこれらの使用
CA2338147A1 (en) Substituted benzimidazole antiviral agents
WO2003066622A1 (en) Novel benzimidazole compounds
CN109851614B (zh) 一类杂环类肽脱甲酰基酶抑制剂及其制备方法和应用
FR2933701A1 (fr) Derives anticancereux, leur preparation et leur application en therapeutique
WO2013142326A1 (en) 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis
HK1141948A (en) Benzimidazoles and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired